Article

AMO sharpens focus on innovative technology

Author(s):

Mark L. Dlugoss

A sign of an excellent company is one that capitalizes on its strengths, minimizes its weaknesses, takes advantage of its opportunities, and recognizes its threats, according to James V. Mazzo, president and chief executive officer of Advanced Medical Optics (AMO).

Related Videos
(Image credit: Ophthalmology Times) NeuroOp Guru: The role of muscle biopsy in heteroplasmy detection
(Image credit: Ophthalmology Times) AGS 2025: Achieving success as an academic ophthalmologist with Thomas V. Johnson III, MD, PhD
(Image credit: Ophthalmology Times) AGS 2025: Constance Okeke, MD, highlights 1-year Streamline canaloplasty outcomes
(Image credit: Ophthalmology Times) AGS 2025: Telemedicine and genetics for resource-efficient care with Louis R. Pasquale, MD
Related Content
(Image credit: AdobeStock/©KayExam/peopleimages.com)
March 10th 2025

A new era for MacTel: Clinicians react to FDA approval of revakinagene taroretcel-lwey

2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco
December 13th 2024

California dreaming: 2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco

Luxa Biotechnology presents clinical data from the phase 1/2a trial evaluating RPESC-RPE-4W
March 10th 2025

Luxa Biotechnology presents clinical data from the phase 1/2a trial evaluating RPESC-RPE-4W

EnVision Summit 2025: Advancing Ophthalmology and Optometry Together
November 19th 2024

Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025

Optos reference database includes highest number of patients of any cleared US database
March 9th 2025

Optos reference database includes highest number of patients of any cleared US database

Altris AI launches advanced glaucoma Optic Disc Analysis module
March 9th 2025

Altris AI launches advanced glaucoma Optic Disc Analysis module

© 2025 MJH Life Sciences

All rights reserved.